Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease.


Journal

Nature microbiology
ISSN: 2058-5276
Titre abrégé: Nat Microbiol
Pays: England
ID NLM: 101674869

Informations de publication

Date de publication:
01 Mar 2024
Historique:
received: 28 01 2023
accepted: 22 01 2024
medline: 2 3 2024
pubmed: 2 3 2024
entrez: 1 3 2024
Statut: aheadofprint

Résumé

Microbial transformation of bile acids affects intestinal immune homoeostasis but its impact on inflammatory pathologies remains largely unknown. Using a mouse model of graft-versus-host disease (GVHD), we found that T cell-driven inflammation decreased the abundance of microbiome-encoded bile salt hydrolase (BSH) genes and reduced the levels of unconjugated and microbe-derived bile acids. Several microbe-derived bile acids attenuated farnesoid X receptor (FXR) activation, suggesting that loss of these metabolites during inflammation may increase FXR activity and exacerbate the course of disease. Indeed, mortality increased with pharmacological activation of FXR and decreased with its genetic ablation in donor T cells during mouse GVHD. Furthermore, patients with GVHD after allogeneic hematopoietic cell transplantation showed similar loss of BSH and the associated reduction in unconjugated and microbe-derived bile acids. In addition, the FXR antagonist ursodeoxycholic acid reduced the proliferation of human T cells and was associated with a lower risk of GVHD-related mortality in patients. We propose that dysbiosis and loss of microbe-derived bile acids during inflammation may be an important mechanism to amplify T cell-mediated diseases.

Identifiants

pubmed: 38429422
doi: 10.1038/s41564-024-01617-w
pii: 10.1038/s41564-024-01617-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Hamilton, J. P. et al. Human cecal bile acids: concentration and spectrum. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G256–G263 (2007).
pubmed: 17412828 doi: 10.1152/ajpgi.00027.2007
Chen, M. L., Takeda, K. & Sundrud, M. S. Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunol. 12, 851–861 (2019).
pubmed: 30952999 doi: 10.1038/s41385-019-0162-4
Belkaid, Y. & Hand, T. W. Role of the microbiota in immunity and inflammation. Cell 157, 121–141 (2014).
pubmed: 24679531 pmcid: 4056765 doi: 10.1016/j.cell.2014.03.011
Russell, D. W. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 72, 137–174 (2003).
pubmed: 12543708 doi: 10.1146/annurev.biochem.72.121801.161712
Ridlon, J. M., Kang, D. J. & Hylemon, P. B. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47, 241–259 (2006).
pubmed: 16299351 doi: 10.1194/jlr.R500013-JLR200
Begley, M., Hill, C. & Gahan, C. G. Bile salt hydrolase activity in probiotics. Appl. Environ. Microbiol. 72, 1729–1738 (2006).
pubmed: 16517616 pmcid: 1393245 doi: 10.1128/AEM.72.3.1729-1738.2006
Wells, J. E. & Hylemon, P. B. Identification and characterization of a bile acid 7alpha-dehydroxylation operon in Clostridium sp. strain TO-931, a highly active 7alpha-dehydroxylating strain isolated from human feces. Appl. Environ. Microbiol. 66, 1107–1113 (2000).
pubmed: 10698778 pmcid: 91949 doi: 10.1128/AEM.66.3.1107-1113.2000
Devlin, A. S. & Fischbach, M. A. A biosynthetic pathway for a prominent class of microbiota-derived bile acids. Nat. Chem. Biol. 11, 685–690 (2015).
pubmed: 26192599 pmcid: 4543561 doi: 10.1038/nchembio.1864
Quinn, R. A. et al. Global chemical effects of the microbiome include new bile-acid conjugations. Nature 579, 123–129 (2020).
pubmed: 32103176 pmcid: 7252668 doi: 10.1038/s41586-020-2047-9
Foley, M. H. et al. Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut. Nat. Microbiol. 8, 611–628 (2023).
pubmed: 36914755 pmcid: 10066039 doi: 10.1038/s41564-023-01337-7
Patterson, A. et al. Bile acids are substrates for amine n-acyl transferase activity by bile salt hydrolase. Preprint at Res. Square https://doi.org/10.21203/rs.3.rs-2050120/v1 (2022).
Shin, D. J. & Wang, L. Bile acid-activated receptors: a review on FXR and other nuclear receptors. Handb. Exp. Pharmacol. 256, 51–72 (2019).
pubmed: 31230143 doi: 10.1007/164_2019_236
Hang, S. et al. Bile acid metabolites control T(H)17 and T(reg) cell differentiation. Nature 576, 143–148 (2019).
pubmed: 31776512 pmcid: 6949019 doi: 10.1038/s41586-019-1785-z
Paik, D. et al. Human gut bacteria produce Τ(Η)17-modulating bile acid metabolites. Nature 603, 907–912 (2022).
pubmed: 35296854 pmcid: 9132548 doi: 10.1038/s41586-022-04480-z
Campbell, C. et al. Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells. Nature 581, 475–479 (2020).
pubmed: 32461639 pmcid: 7540721 doi: 10.1038/s41586-020-2193-0
Gratwohl, A. et al. Hematopoietic stem cell transplantation: a global perspective. JAMA 303, 1617–1624 (2010).
pubmed: 20424252 pmcid: 3219875 doi: 10.1001/jama.2010.491
Gooley, T. A. et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N. Engl. J. Med. 363, 2091–2101 (2010).
pubmed: 21105791 pmcid: 3017343 doi: 10.1056/NEJMoa1004383
Aljurf, M. et al. Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries. Bone Marrow Transpl. 54, 1179–1188 (2019).
doi: 10.1038/s41409-019-0476-6
Peled, J. U. et al. Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. N. Engl. J. Med. 382, 822–834 (2020).
pubmed: 32101664 pmcid: 7534690 doi: 10.1056/NEJMoa1900623
Taur, Y. et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 124, 1174–1182 (2014).
pubmed: 24939656 pmcid: 4133489 doi: 10.1182/blood-2014-02-554725
Jenq, R. R. et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J. Exp. Med. 209, 903–911 (2012).
pubmed: 22547653 pmcid: 3348096 doi: 10.1084/jem.20112408
Holler, E. et al. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol. Blood Marrow Transpl. 20, 640–645 (2014).
doi: 10.1016/j.bbmt.2014.01.030
Burgos da Silva, M. et al. Preservation of fecal microbiome is associated with reduced severity of graft-versus-host disease. Blood 140, 2385–2397 (2022).
Taur, Y. et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin. Infect. Dis. 55, 905–914 (2012).
pubmed: 22718773 pmcid: 3657523 doi: 10.1093/cid/cis580
Ara, T. & Hashimoto, D. Novel insights into the mechanism of GVHD-induced tissue damage. Front. Immunol. 12, 713631 (2021).
pubmed: 34512636 pmcid: 8429834 doi: 10.3389/fimmu.2021.713631
Zeiser, R. & Blazar, B. R. Acute graft-versus-host disease – biologic process, prevention, and therapy. N. Engl. J. Med. 377, 2167–2179 (2017).
pubmed: 29171820 pmcid: 6034180 doi: 10.1056/NEJMra1609337
Malard, F., Holler, E., Sandmaier, B. M., Huang, H. & Mohty, M. Acute graft-versus-host disease. Nat. Rev. Dis. Prim. 9, 27 (2023).
pubmed: 37291149 doi: 10.1038/s41572-023-00438-1
Reddy, P., Negrin, R. & Hill, G. R. Mouse models of bone marrow transplantation. Biol. Blood Marrow Transpl. 14, 129–135 (2008).
doi: 10.1016/j.bbmt.2007.10.021
Palmer, R. H. The formation of bile acid sulfates: a new pathway of bile acid metabolism in humans. Proc. Natl Acad. Sci. USA 58, 1047–1050 (1967).
pubmed: 5234601 pmcid: 335745 doi: 10.1073/pnas.58.3.1047
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
pubmed: 16199517 pmcid: 1239896 doi: 10.1073/pnas.0506580102
Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267–273 (2003).
pubmed: 12808457 doi: 10.1038/ng1180
Gadaleta, R. M. et al. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut 60, 463–472 (2011).
pubmed: 21242261 doi: 10.1136/gut.2010.212159
Campbell, C. et al. FXR mediates T cell-intrinsic responses to reduced feeding during infection. Proc. Natl Acad. Sci. USA 117, 33446–33454 (2020).
pubmed: 33318189 pmcid: 7776647 doi: 10.1073/pnas.2020619117
Sayin, S. I. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225–235 (2013).
pubmed: 23395169 doi: 10.1016/j.cmet.2013.01.003
Shono, Y. et al. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci. Transl. Med. 8, 339ra371 (2016).
doi: 10.1126/scitranslmed.aaf2311
Ruutu, T. et al. Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood 100, 1977–1983 (2002).
pubmed: 12200355 doi: 10.1182/blood-2001-12-0159
Ruutu, T. et al. Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study. Biol. Blood Marrow Transpl. 20, 135–138 (2014).
doi: 10.1016/j.bbmt.2013.10.014
Guzior, D. V. & Quinn, R. A. Review: microbial transformations of human bile acids. Microbiome 9, 140 (2021).
pubmed: 34127070 pmcid: 8204491 doi: 10.1186/s40168-021-01101-1
Claudel, T., Staels, B. & Kuipers, F. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler Thromb. Vasc. Biol. 25, 2020–2030 (2005).
pubmed: 16037564 doi: 10.1161/01.ATV.0000178994.21828.a7
Cox, D. R. Regression models and life-tables. J. R. Stat. Soc. B 34, 187–202 (1972).
Fine, J. P. & Gray, R. J. A proportional hazards model for the subdistribution of a competing risk. Theory Method 94, 496–509 (1997).
Haring, E. et al. Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect. Haematologica 106, 2131–2146 (2021).
pubmed: 32675222 doi: 10.3324/haematol.2019.242990
Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe 15, 382–392 (2014).
pubmed: 24629344 pmcid: 4059512 doi: 10.1016/j.chom.2014.02.005
Peled, J. U. et al. Intestinal microbiota and relapse after hematopoietic-cell transplantation. J. Clin. Oncol. 35, 1650–1659 (2017).
pubmed: 28296584 pmcid: 5455763 doi: 10.1200/JCO.2016.70.3348
McCarville, J. L., Chen, G. Y., Cuevas, V. D., Troha, K. & Ayres, J. S. Microbiota metabolites in health and disease. Annu. Rev. Immunol. 38, 147–170 (2020).
pubmed: 32340573 doi: 10.1146/annurev-immunol-071219-125715
Yao, L. et al. A selective gut bacterial bile salt hydrolase alters host metabolism. Elife 7, e37182 (2018).
pubmed: 30014852 pmcid: 6078496 doi: 10.7554/eLife.37182
Zhang, Y. et al. Ursodeoxycholic acid accelerates bile acid enterohepatic circulation. Br. J. Pharmacol. 176, 2848–2863 (2019).
pubmed: 31077342 pmcid: 6637225 doi: 10.1111/bph.14705
Winston, J. A., Rivera, A., Cai, J., Patterson, A. D. & Theriot, C. M. Secondary bile acid ursodeoxycholic acid alters weight, the gut microbiota, and the bile acid pool in conventional mice. PLoS ONE 16, e0246161 (2021).
pubmed: 33600468 pmcid: 7891722 doi: 10.1371/journal.pone.0246161
Song, X. et al. Microbial bile acid metabolites modulate gut RORγ(+) regulatory T cell homeostasis. Nature 577, 410–415 (2020).
pubmed: 31875848 doi: 10.1038/s41586-019-1865-0
Li, W. et al. A bacterial bile acid metabolite modulates T(reg) activity through the nuclear hormone receptor NR4A1. Cell Host Microbe 29, 1366–1377.e9 (2021).
Lee, J. W. J. et al. Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease. Cell Host Microbe 29, 1294–1304.e4 (2021).
pubmed: 34297922 pmcid: 8366279 doi: 10.1016/j.chom.2021.06.019
Gopalakrishnan, V. et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359, 97–103 (2018).
pubmed: 29097493 doi: 10.1126/science.aan4236
Smith, M. et al. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. Nat. Med. 28, 713–723 (2022).
pubmed: 35288695 pmcid: 9434490 doi: 10.1038/s41591-022-01702-9
Stein-Thoeringer, C. K. et al. Lactose drives Enterococcus expansion to promote graft-versus-host disease. Science 366, 1143–1149 (2019).
pubmed: 31780560 pmcid: 7003985 doi: 10.1126/science.aax3760
Mathewson, N. D. et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat. Immunol. 17, 505–513 (2016).
pubmed: 26998764 pmcid: 4836986 doi: 10.1038/ni.3400
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
pubmed: 25605792 pmcid: 4402510 doi: 10.1093/nar/gkv007
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289–300 (1995).
Andrews, S. FastQC v.0.11.9 (Babraham Bioinformatics, 2015).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).
Peled, J. U., Gomes, A. L. C. & van den Brink, M. R. M. Microbiota and allogeneic hematopoietic-cell transplantation. Reply. N. Engl. J. Med. 382, 2378–2379 (2020).
pubmed: 32521145 doi: 10.1056/NEJMoa1900623
Miltiadous, O. et al. Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant. Blood 139, 2758–2769 (2022).
pubmed: 35061893 pmcid: 9074404 doi: 10.1182/blood.2021014255
Callahan, B. J., McMurdie, P. J. & Holmes, S. P. Exact sequence variants should replace operational taxonomic units in marker-gene data analysis. ISME J. 11, 2639–2643 (2017).
pubmed: 28731476 pmcid: 5702726 doi: 10.1038/ismej.2017.119
Callahan, B. J. et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581–583 (2016).
pubmed: 27214047 pmcid: 4927377 doi: 10.1038/nmeth.3869
Dubin, K. A. et al. Diversification and evolution of vancomycin-resistant Enterococcus faecium during intestinal domination. Infect. Immun. 87, e00102–e00119 (2019).
pubmed: 31010813 pmcid: 6589067 doi: 10.1128/IAI.00102-19
Beghini, F. et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife 10, e65088 (2021).
pubmed: 33944776 pmcid: 8096432 doi: 10.7554/eLife.65088
Buchfink, B., Xie, C. & Huson, D. H. Fast and sensitive protein alignment using DIAMOND. Nat. Methods 12, 59–60 (2015).
pubmed: 25402007 doi: 10.1038/nmeth.3176
Buchfink, B., Reuter, K. & Drost, H. G. Sensitive protein alignments at tree-of-life scale using DIAMOND. Nat. Methods 18, 366–368 (2021).
pubmed: 33828273 pmcid: 8026399 doi: 10.1038/s41592-021-01101-x
Menzel, P., Ng, K. L. & Krogh, A. Fast and sensitive taxonomic classification for metagenomics with Kaiju. Nat. Commun. 7, 11257 (2016).
pubmed: 27071849 pmcid: 4833860 doi: 10.1038/ncomms11257
Stoeckius, M. et al. Cell hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics. Genome Biol. 19, 224 (2018).
pubmed: 30567574 pmcid: 6300015 doi: 10.1186/s13059-018-1603-1
Lun, A. T. L. et al. EmptyDrops: distinguishing cells from empty droplets in droplet-based single-cell RNA sequencing data. Genome Biol. 20, 63 (2019).
pubmed: 30902100 pmcid: 6431044 doi: 10.1186/s13059-019-1662-y
Kousa, A. I. & Lemarquis, A. The shunPykeR’s guide to single cell analysis (v.1.0.0). GitHub https://github.com/kousaa/shunPykeR?tab=readme-ov-file (2023).
Traag, V. A., Waltman, L. & van Eck, N. J. From Louvain to Leiden: guaranteeing well-connected communities. Sci. Rep. 9, 5233 (2019).
pubmed: 30914743 pmcid: 6435756 doi: 10.1038/s41598-019-41695-z
Wolock, S. L., Lopez, R. & Klein, A. M. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 8, 281–291.e9 (2019).
pubmed: 30954476 pmcid: 6625319 doi: 10.1016/j.cels.2018.11.005
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
pubmed: 31740819 pmcid: 6884693 doi: 10.1038/s41592-019-0619-0
Ntranos, V., Yi, L., Melsted, P. & Pachter, L. A discriminative learning approach to differential expression analysis for single-cell RNA-seq. Nat. Methods 16, 163–166 (2019).
pubmed: 30664774 doi: 10.1038/s41592-018-0303-9

Auteurs

Sarah Lindner (S)

Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Oriana Miltiadous (O)

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Ruben J F Ramos (RJF)

Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Jenny Paredes (J)

Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Anastasia I Kousa (AI)

Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Anqi Dai (A)

Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Teng Fei (T)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Emma Lauder (E)

Transplantation and Cell Therapy Program, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.

John Frame (J)

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Nicholas R Waters (NR)

Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Keimya Sadeghi (K)

Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Gabriel K Armijo (GK)

Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Romina Ghale (R)

Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Kristen Victor (K)

Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Brianna Gipson (B)

Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Sebastien Monette (S)

Center of Comparative Medicine and Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Marco Vincenzo Russo (MV)

Gene Editing and Screening Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA.

Chi L Nguyen (CL)

Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

John Slingerland (J)

Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Ying Taur (Y)

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Kate A Markey (KA)

Division of Medical Oncology, University of Washington, Seattle, WA, USA.
Fred Hutchinson Cancer Center, Seattle, WA, USA.

Hana Andrlova (H)

Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Sergio Giralt (S)

Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Medicine, Weill Cornell Medical College, New York, NY, USA.

Miguel-Angel Perales (MA)

Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Medicine, Weill Cornell Medical College, New York, NY, USA.

Pavan Reddy (P)

Transplantation and Cell Therapy Program, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.

Jonathan U Peled (JU)

Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Medicine, Weill Cornell Medical College, New York, NY, USA.

Melody Smith (M)

Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Justin R Cross (JR)

Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Marina Burgos da Silva (M)

Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Clarissa Campbell (C)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria. ccampbell@cemm.oeaw.ac.at.

Marcel R M van den Brink (MRM)

Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. mvandenbrink@coh.org.
Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. mvandenbrink@coh.org.
Department of Medicine, Weill Cornell Medical College, New York, NY, USA. mvandenbrink@coh.org.
Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA. mvandenbrink@coh.org.
Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA. mvandenbrink@coh.org.
Comprehensive Cancer Center, City of Hope, Los Angeles, CA, USA. mvandenbrink@coh.org.

Classifications MeSH